Production of first generation adenovirus vectors: a review
- PMID: 11083491
- DOI: 10.1038/sj.gt.3301301
Production of first generation adenovirus vectors: a review
Abstract
In the past decade, adenovirus vectors have generated tremendous interest, especially in gene therapy applications. In the so-called 'first generation' adenovirus vectors, the transgenes are inserted in place of the E1 region, or less often the E3 region. Although second-generation and helper-dependent adenovirus vectors will probably prevail in the future in applications that require long-term gene expression, first generation adenovirus vectors will remain very useful in other settings, such as cancer and vaccination, or simply to transfect cell lines that are refractory to other transfection methods. Until a few years ago, the construction of first generation adenovirus vectors was a labor-intensive and time-consuming process. More than 20 methods have appeared that facilitate their construction and are reviewed below.
Similar articles
-
Gutless adenovirus: last-generation adenovirus for gene therapy.Gene Ther. 2005 Oct;12 Suppl 1:S18-27. doi: 10.1038/sj.gt.3302612. Gene Ther. 2005. PMID: 16231052 Review.
-
Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals.Mol Ther. 2001 Feb;3(2):206-15. doi: 10.1006/mthe.2000.0244. Mol Ther. 2001. PMID: 11237677
-
[Adenovirus vectors and their clinical application in gene therapy].Orv Hetil. 2001 Sep 23;142(38):2061-70. Orv Hetil. 2001. PMID: 11697063 Review. Hungarian.
-
Helper-dependent adenovirus vectors devoid of all viral genes cause less myocardial inflammation compared with first-generation adenovirus vectors.Basic Res Cardiol. 2004 Jul;99(4):247-56. doi: 10.1007/s00395-004-0471-x. Epub 2004 Mar 22. Basic Res Cardiol. 2004. PMID: 15221342
-
A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear function.Gene Ther. 2001 May;8(10):789-94. doi: 10.1038/sj.gt.3301445. Gene Ther. 2001. PMID: 11420643
Cited by
-
Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cells.Mol Ther Methods Clin Dev. 2022 Mar 7;25:96-110. doi: 10.1016/j.omtm.2022.03.004. eCollection 2022 Jun 9. Mol Ther Methods Clin Dev. 2022. PMID: 35402633 Free PMC article.
-
High-efficiency system for the construction of adenovirus vectors and its application to the generation of representative adenovirus-based cDNA expression libraries.J Virol. 2006 Jun;80(11):5435-50. doi: 10.1128/JVI.00218-06. J Virol. 2006. PMID: 16699024 Free PMC article.
-
Use of adenoviral vectors as veterinary vaccines.Gene Ther. 2005 Oct;12 Suppl 1(Suppl 1):S73-83. doi: 10.1038/sj.gt.3302618. Gene Ther. 2005. PMID: 16231058 Free PMC article. Review.
-
Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.Genes Dis. 2017 Jun;4(2):43-63. doi: 10.1016/j.gendis.2017.04.001. Epub 2017 Apr 27. Genes Dis. 2017. PMID: 28944281 Free PMC article.
-
Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.Int J Mol Sci. 2017 Mar 23;18(4):686. doi: 10.3390/ijms18040686. Int J Mol Sci. 2017. PMID: 28420073 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous